UBS analyst Kevin McVeigh initiated coverage of TransUnion with a Neutral rating and $110 price target The shares have outperformed year-to-date on a consumer credit recovery, the analyst tells investors in a research note. The firm says TransUnion’s higher-growth geographies, new product innovation, and counter-cyclical collections verticals are balanced by its less leverage to mortgage, “more episodic” breach-related revenue boost and hybrid public-private tech stack possibly slowing the pace of innovation,
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRU:
- TransUnion, MoneyLion partner to deliver personalized financial products
- TransUnion price target raised to $105 from $80 at Barclays
- TransUnion strengthens parntership with Truework
- TransUnion price target raised to $103 from $96 at Morgan Stanley
- Equifax price target raised to $271 from $250 at Morgan Stanley